Strong correlation between the 6-minute walk test and accelerometry functional outcomes in boys with duchenne muscular dystrophy

Journal of Child Neurology

Volumn 30, Issue 3, 2015, Pages 357-363

  Davidson, Zoe E ^a,c   Ryan, Monique M ^b,c   Kornberg, Andrew J ^b,c   Walker, Karen Z ^a   Truby, Helen ^a  

^a MONASH UNIVERSITY   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

6 minute walk test; accelerometry; Duchenne; muscular dystrophy; StepWatch

Indexed keywords

DEFLAZACORT; DYSTROPHIN; PREDNISOLONE;

6 MINUTE WALK TEST; ACCELEROMETRY; ADOLESCENT; AGE; ARTICLE; BODY MASS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; DUCHENNE MUSCULAR DYSTROPHY; FUNCTIONAL ASSESSMENT; GENE MUTATION; HUMAN; MALE; MOBILIZATION; MUSCULOSKELETAL SYSTEM EXAMINATION; OUTCOME ASSESSMENT; PHYSICAL INACTIVITY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; STEPWATCH ACTIVITY MONITOR; WALKING; ANTHROPOMETRY; DISEASE COURSE; EXERCISE TEST; GENETICS; MUSCULAR DYSTROPHY, DUCHENNE; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PHYSIOLOGY; STATISTICS; TIME;

ACCELEROMETRY; ADOLESCENT; ANTHROPOMETRY; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; EXERCISE TEST; HUMANS; MALE; MUSCULAR DYSTROPHY, DUCHENNE; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICAL EXAMINATION; STATISTICS AS TOPIC; TIME FACTORS; WALKING;

EID: 84923358969     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073814530502     Document Type: Article

References (22)

1. Bushby K, Finkel R, Birnkrant DJ, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 2010 ; 9: 77-93
2. Rall S, Grimm T. Survival in Duchenne muscular dystrophy. Acta Myol. 2012 ; 31: 117-120
3. McDonald CM, Henricson EK, Han JJ, et al. The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy. Muscle Nerve. 2010 ; 41: 500-510
4. Mayhew J, Florence J, Mayhew TP, et al. Reliable surrogate outcome measures in multicentre clinical trials of Duchenne muscular dystrophy. Muscle Nerve. 2007 ; 35: 36-42
5. McDonald CM, Widman LM, Walsh DD, et al. Use of step activity monitoring for continuous physical activity assessment in boys with Duchenne muscular dystrophy. Arch Phys Med Rehabil. 2005 ; 86: 802-808
6. Kuczmarski R, Ogden C, Grummer-Strawn L, et al. CDC growth charts: United States. Adv Data. 2000 ; (314). 1-27
7. ATS Statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002 ; 166: 111-117
8. Taylor R. Interpretation of the correlation coefficient: a basic review. J Diagn Med Sonogr. 1990 ; 6: 35-39
9. McDonald CM, Henricson EK, Han JJ, et al. The 6-minute walk test in Duchenne/Becker muscular dystrophy: longitudinal observations. Muscle Nerve. 2010 ; 42: 966-974
10. Mazzone E, Vasco G, Sormani MP, et al. Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study. Neurology. 2011 ; 77: 250-256
11. Henricson E, Abresch R, Han JJ. Percent-Predicted 6-minute walk distance in Duchenne muscular dystrophy to account for maturational influences. PLoS Curr. 2012 ;: 4
12. McDonald C, Coleman K, Henricson E, et al. Assessment of StepWatch™ activity monitoring in phase 2b study of ataluren (PTC124™) in nmDMD/BMD. Neuromuscul Disord. 2009 ; 19: 602
13. McDonald CM, Widman L, Abresch RT, et al. Utility of a step activity monitor for the measurement of daily ambulatory activity in children. Arch Phys Med Rehabil. 2005 ; 86: 793-801
14. Song KM, Bjornson KF, Cappello T, et al. Use of the StepWatch activity monitor for characterization of normal activity levels of children. J Pediatr Orthop. 2006 ; 26: 245-249
15. De Vries SI, Van Hirtum HWJEM, Bakker I, et al. Validity and reproducibility of motion sensors in youth: a systematic update. Med Sci Sports Exerc. 2009 ; 41: 818-827
16. Oftedal S, Bell KL, Mitchell LE, et al. A systematic review of the clinimetric properties of habitual physical activity measures in young children with a motor disability. Int J Pediatr. 2012;2012 ;: 976425
17. Moxley RT, Pandya S, Ciafaloni E, et al. Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management. J Child Neurol. 2010 ; 25: 1116-1129
18. Elliott SA, Davidson ZE, Davies PSW, et al. Predicting resting energy expenditure in boys with Duchenne muscular dystrophy. Eur J Paediatr Neurol. 2012 ; 16: 631-635
19. Janz KF, Cassady SL, Barr RN, et al. Monitoring exercise in children and adolescents with cystic fibrosis: validation of the CSA accelerometer. Cardiopulm Phys Ther J. 1995 ; 6: 3-8
20. Norman JF. Accelerometry as an estimate of energy expenditure in healthy children and children with cerebral palsy during self-paced ambulation. IJAHSP. 2006 ; 4: 1-5
21. McDonald CM, Abresch RT, Carter GT, et al. Profiles of neuromuscular diseases. Duchenne muscular dystrophy. Am J Phys Med Rehabil. 1995 ; 74: S70 - S92
22. Willig TN, Carlier L, Legrand M, et al. Nutritional assessment in Duchenne muscular dystrophy. Dev Med Child Neurol. 1993 ; 35: 1074-1082